Forte Biosciences's total assets for Q3 2024 were $17.95M, a decrease of -31.18% from the previous quarter. FBRX total liabilities were $8.58M for the fiscal quarter, a -5.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.